Agenda and minutes
Venue: Committee Room 3 - Senedd. View directions
Contact: Llinos Madeley
Media
Senedd.TV: View the webcast
Expected timing | No. | Item |
---|---|---|
Transcript View the meeting transcript. |
||
(09.00 - 09.45) |
The Committee's forward work programme Supporting documents:
Minutes: 1.1
The Committee
agreed to undertake an inquiry into alcohol and substance misuse. Members
considered and agreed the terms of reference and the Committee’s approach to
the inquiry. |
|
(09.45) |
Introductions, apologies and substitutions Minutes: 2.1 Apologies were received from Lynne Neagle. Ann Jones acted as a substitute. |
|
(09.45 - 10.30) |
Inquiry into new psychoactive substances (“legal highs”): Evidence session 1 Jeremy Sare, Angelus
Foundation Maryon Stewart, Angelus Foundation Harry Shapiro, DrugScope Supporting documents:
Minutes: 3.1
Apologies were received from Maryon Stewart. 3.2
The witnesses responded to questions from Members. |
|
(10.45 - 11.30) |
Inquiry into new psychoactive substances (“legal highs”): Evidence session 2 Professor Philip Routledge OBE, Chair of the
Programme Board, Welsh Emerging Drugs and Identification of Novel Substances
(WEDINOS) Josephine Smith, Programme Lead, WEDINOS Dr Quentin Sandifer, Public Health Wales Supporting documents: Minutes: 4.1
The witnesses responded to questions from Members. 4.2
Dr Quentin Sandifer agreed to supply the Committee with additional information
about how Public Health Wales engages and communicates with communities in
Wales about new psychoactive substances. 4.3
The Committee agreed to write to TICTAC to seek clarification on whether they
test the substances received in addition to providing visual drug
identification. |
|
(11.30 - 12.15) |
Inquiry into new psychoactive substances (“legal highs”): Evidence session 3 Joanne Davies, Assistant Director of Planning,
Abertawe Bro Morgannwg University Health Board Jamie Harris, Families Children and Young Persons
Services Manager, SANDS Cymru (formerly known as Swansea Drugs Project)* Nicola John, Director Public Health, Cwm Taf
University Health Board* Dr Julia Lewis, Consultant Addiction Psychiatrist
and Clinical Lead for Addiction, Aneurin Bevan University Health Board Dr Jonathan Whelan, Assistant Medical Director,
Welsh Ambulance Service NHS Trust* *Written papers have not been submitted Supporting documents:
Minutes: 5.1
The witnesses responded to questions from Members. |
|
(13.15 - 14.15) |
Inquiry into new psychoactive substances (“legal highs”): Evidence session 4 Kathryn Peters, Community Safety Manager for
Caerphilly County Borough Council Councillor Mark Child, Trading Standards portfolio
holder Swansea Council Councillor Andrea Lewis, Swansea Council Angela Cronin, Development Worker for Health &
Wellbeing, Bridgend Youth Service Richard Webb, Association of Chief Trading
Standards Officers, Oxfordshire
County Council Supporting documents:
Minutes: 6.1
Apologies were received from Councillor Mark Child. Jackie Garland acted as
substitute. 6.2
The witnesses responded to questions from Members. 6.3
Richard Webb agreed to provide further information about a toolkit that is
being developed by trading standards officers on how to approach the issue of
new psychoactive substances. He also agreed to provide a view in writing about
the impact of the Anti-Social Behaviour Crime and Policing Act 2014 on trading
standards officers’ approach to new psychoactive substances. |
|
(14.15) |
Papers to note Supporting documents:
Minutes: 7.0a The Committee noted the minutes of the meetings on 16 and 22 October. |
|
Inquiry into new psychoactive substances (“legal highs”): Note from the visits held on 2 October 2014 Supporting documents:
Minutes: 7.1a
The Committee noted the note of the visits held on 2 October 2014 in relation
to the inquiry into new psychoactive substances (“legal highs”). |
||
Inquiry into new psychoactive substances (“legal highs”): Note from the focus group events held on 2 October 2014 Supporting documents:
Minutes: 7.2a
The Committee noted the note of the focus groups held on 2 October 2014 in
relation to the inquiry into new psychoactive substances (“legal highs”). |
||
Inquiry into new psychoactive substances (“legal highs”): Results of the Committee's survey Supporting documents: Minutes: 7.3a
The Committee noted the results of the Committee’s survey in relation to the inquiry
into new psychoactive substances (“legal highs”). |
||
Inquiry into new psychoactive substances (“legal highs”): Consultation responses Supporting documents:
Minutes: 7.4a
The Committee noted the consultation responses in relation to the inquiry into
new psychoactive substances (“legal highs”). |
||
Public Health White Paper: Follow up from 8 October 2014 Supporting documents:
Minutes: 7.5a
The Committee noted the responses from both the Minister for Health and Social
Services and the Chief Medical Officer in relation to the factual briefing on
the Public Health White Paper. |
||
Correspondence from the Petitions Committee: P-04-568 Public Inquiry into ABMU Health Board Supporting documents:
Minutes: 7.6a
The Committee agreed to write to the Chair of Petitions Committee to inform the
Petitions Committee that although this is not a matter the Health and Social
Care Committee is considering currently, the Public Accounts Committee is
undertaking a piece of work on health board governance in NHS Wales The Health
and Social Care Committee agreed to await the outcome of that inquiry before
considering the matter further. |
||
(14.15) |
Motion under Standing Order 17.42(vi) to resolve to exclude the public from the remainder of the meeting Minutes: 8.1
The motion was agreed. |
|
(14.15 - 14.45) |
Inquiry into new psychoactive substances (“legal highs”): Consideration of evidence received Minutes: 9.1
The Committee considered the evidence received on the inquiry. |